Abstract
Glucocorticoid receptor (GR), a member of the steroid receptor superfamily, can mediate the signal pathway of ligands like glucocorticoids, regulate the transcription of target genes, and exert biological activity. GR is expressed in different degrees in three major kinds of urological malignant tumors including renal cancer, bladder cancer and prostate cancer. It also affects the metabolism of tumor cells, and is closely related to the occurrence, development and prognosis of tumors. GR provides an important clue for targeted therapy and endocrine therapy of urological malignant tumors. Key words: Receptors, glucocorticoid; Kidney neoplasms; Urinary bladder neoplasms; Prostatic neoplasms
Sign-in/Register to access full text options 
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
